Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial

Summary Background Robust evidence of the effectiveness of task shifting of antiretroviral therapy (ART) from doctors to other health workers is scarce. We aimed to assess the effects on mortality, viral suppression, and other health outcomes and quality indicators of the Streamlining Tasks and Role...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2012-09, Vol.380 (9845), p.889-898
Hauptverfasser: Fairall, Lara, PhD, Bachmann, Max O, Prof, Lombard, Carl, PhD, Timmerman, Venessa, MSc, Uebel, Kerry, MBChB, Zwarenstein, Merrick, PhD, Boulle, Andrew, PhD, Georgeu, Daniella, Dip Nursing, Colvin, Christopher J, PhD, Lewin, Simon, PhD, Faris, Gill, Dip General Nursing, Cornick, Ruth, MBChB, Draper, Beverly, MBChB, Tshabalala, Mvula, MBChB, Kotze, Eduan, PhD, van Vuuren, Cloete, MBChB, Steyn, Dewald, MBChB, Chapman, Ronald, MMed, Bateman, Eric, Prof
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Background Robust evidence of the effectiveness of task shifting of antiretroviral therapy (ART) from doctors to other health workers is scarce. We aimed to assess the effects on mortality, viral suppression, and other health outcomes and quality indicators of the Streamlining Tasks and Roles to Expand Treatment and Care for HIV (STRETCH) programme, which provides educational outreach training of nurses to initiate and represcribe ART, and to decentralise care. Methods We undertook a pragmatic, parallel, cluster-randomised trial in South Africa between Jan 28, 2008, and June 30, 2010. We randomly assigned 31 primary-care ART clinics to implement the STRETCH programme (intervention group) or to continue with standard care (control group). The ratio of randomisation depended on how many clinics were in each of nine strata. Two cohorts were enrolled: eligible patients in cohort 1 were adults (aged ≥16 years) with CD4 counts of 350 cells per μL or less who were not receiving ART; those in cohort 2 were adults who had already received ART for at least 6 months and were being treated at enrolment. The primary outcome in cohort 1 was time to death (superiority analysis). The primary outcome in cohort 2 was the proportion with undetectable viral loads (
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(12)60730-2